INFRATIL LIMITED (IFT)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

IFT

IFT - INFRATIL LIMITED

FNArena Sector : Wealth Management & Investments
Year End: March
GICS Industry Group : Capital Goods
Debt/EBITDA: 20.91
Index: ASX200 | ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$9.48

01 Apr
2026

-0.140

OPEN

$9.58

-1.46%

HIGH

$9.70

413,977

LOW

$9.31

TARGET
$11.82 24.7% upside
OTHER COMPANIES IN THE SAME SECTOR
AEF . AMP . ASX . BVS . CGF . CVW . DJW . ENN . GDG . GQG . HMC . HUB . IFL . IRE . KAM . KSL . MAF . MFG . MQG . NGI . NWL . PAC . PNI . PPS . PPT . QAL . RPL . RZI . WHF .
FNARENA'S MARKET CONSENSUS FORECASTS
IFT: 1
Title FY24
Actual		 FY25
Actual		 FY26
Forecast		 FY27
Forecast
EPS (cps) xxx - 27.9 25.2 xxx
DPS (cps) xxx 18.7 18.4 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx - 5.6% - 1.6% xxx
PE Ratio xxx N/A 37.4 xxx
Dividend Yield xxx N/A 1.9% xxx
Div Pay Ratio(%) xxx N/A 72.8% xxx

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 N/A

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 26/11 - (franking ex-div 8c)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx-27.9
DPS All xxxxxxxxxxxxxxx18.7
Sales/Revenue xxxxxxxxxxxxxxx2,945.6 M
Book Value Per Share xxxxxxxxxxxxxxx625.4
Net Operating Cash Flow xxxxxxxxxxxxxxx351.7 M
Net Profit Margin xxxxxxxxxxxxxxx-8.85 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx-4.54 %
Return on Invested Capital xxxxxxxxxxxxxxx-2.24 %
Return on Assets xxxxxxxxxxxxxxx-1.68 %
Return on Equity xxxxxxxxxxxxxxx-4.54 %
Return on Total Capital xxxxxxxxxxxxxxx-1.94 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-176.9 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx381 M
Long Term Debt xxxxxxxxxxxxxxx6,025 M
Total Debt xxxxxxxxxxxxxxx6,407 M
Goodwill - Gross xxxxxxxxxxxxxxx4,255 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx267 M
Price To Book Value xxxxxxxxxxxxxxx1.51

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx544.6 M
Capex % of Sales xxxxxxxxxxxxxxx18.49 %
Cost of Goods Sold xxxxxxxxxxxxxxx2,470 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx738 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx432 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.9

No. Of Recommendations

4
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

-

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

08/01/2026

2

Initiation of coverage with Accumulate

$11.30

19.20%

Morgans has initiated coverage of Infratil with an Accumulate rating and target price of $11.30.

The broker highlights Infratil is a high-quality structural growth investor targeting 11-15% post-fee returns, with a long-term track record of 18% annual returns over the last 30 years.

At a -30% discount to NAV, a re-rating to a more normal -20% discount could drive 10% share price upside, in the broker's view. Further gains can be supported by ongoing NAV growth, the broker adds.

Key near-term valuation catalysts include the January 2026 CDC independent expert valuation update, potential contract wins and asset divestments at or near book value. Further derisking of renewable investments such as Longroad and Gurin Energy are also potential catalysts.

This report was published January 6.

FORECAST
Morgans forecasts a full year FY26 dividend of 18.03 cents.
Morgans forecasts a full year FY27 dividend of 18.56 cents.

UBS

xx/xx/xxxx

1

xxx

-

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

30/03/2026

1

Buy

-

-

Jarden maintains a Buy rating on Infratil and has lowered its price target to NZ$14.56 following the company's Investor Day.

The target revision is primarily driven by currency movements and updated capital expenditure programs.

The broker highlights strong momentum at CDC Data Centres, which has upgraded its FY27 EBITDA guidance due to increased visibility on contracted capacity.

While FY26 guidance for CDC is at the lower end of the range due to contract timing, commentary suggests the long-term demand outlook remains robust, supported by global hyperscaler investment and significant capacity expansion opportunities through 2030.

FORECAST
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -19.63 cents.
Jarden forecasts a full year FY27 dividend of 0.00 cents and EPS of 1.86 cents.
Access Extra Coverage Research History >

IFT STOCK CHART

FNArena News on IFT

1
Australian Broker Call *Extra* Edition – Mar 30, 2026

Mar 30 2026 - Daily Market Reports
2
Australian Broker Call *Extra* Edition – Nov 19, 2025

Nov 19 2025 - Daily Market Reports
3
FNArena Corporate Results Monitor – 14-11-2025

Nov 14 2025 - Australia
4
Australian Broker Call *Extra* Edition – Oct 28, 2025

Oct 28 2025 - Daily Market Reports
5
Next Week At A Glance – 27-31 Oct 2025

Oct 24 2025 - Weekly Reports

Latest Wealth Management & Investments News

1
Opportunity In ‘Mini Macquarie’ Weakness

Mar 31 2026 - Small Caps
2
Weekly Update On LICs & LITs – 31-Mar-2026

Mar 31 2026 - Weekly Reports
3
Australian Listed Real Estate Tables – 30-03-2026

Mar 30 2026 - Weekly Reports
4
Weekly Update On LICs & LITs – 24-Mar-2026

Mar 24 2026 - Weekly Reports
5
Weekly Update On LICs & LITs – 17-Mar-2026

Mar 17 2026 - Weekly Reports
6
Weekly Update On LICs & LITs – 09-Mar-2026

Mar 10 2026 - Weekly Reports
7
Weekly Update On LICs & LITs – 03-Mar-2026

Mar 03 2026 - Weekly Reports
8
Weekly Update On LICs & LITs – 23-Feb-2026

Feb 24 2026 - Weekly Reports
9
Was AMP’s Punishment Too Much?

Feb 18 2026 - Australia
10
Positive Undercurrent For Macquarie Shares

Feb 17 2026 - Technicals